InvestorsHub Logo
Followers 1
Posts 26
Boards Moderated 0
Alias Born 03/27/2018

Re: Leronlimab4DaWin post# 5151

Friday, 05/11/2018 6:56:19 AM

Friday, May 11, 2018 6:56:19 AM

Post# of 7715
The safety profile is reviewed by the FDA and given a continuation after careful review of the circumstance. It granted Fast Track Designation.

Raising capital is a signal of the Opt In decision after Janssen's continuation announcement. The golden age for Geron is beginning with this ramp up
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News